Cargando…

Cangrelor Use in Routine Practice: A Two-Center Experience

Cangrelor is the first and only intravenous P2Y(12)-inhibitor and is indicated when (timely) administration of an oral P2Y(12) inhibitor is not feasible in patients undergoing percutaneous coronary intervention (PCI). Our study evaluated the first years of cangrelor use in two Dutch tertiary care ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Sangen, Niels M. R., Cheung, Ho Yee, Verouden, Niels J. W., Appelman, Yolande, Beijk, Marcel A. M., Claessen, Bimmer E. P. M., Delewi, Ronak, Knaapen, Paul, Lemkes, Jorrit S., Nap, Alexander, Vis, M. Marije, Kikkert, Wouter J., Henriques, José P. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269409/ https://www.ncbi.nlm.nih.gov/pubmed/34206905 http://dx.doi.org/10.3390/jcm10132829

Ejemplares similares

Detection of Vulnerable Coronary Plaques Using Invasive and Non-Invasive Imaging Modalities
por: van Veelen, Anna, et al.
Publicado: (2022)

One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome
por: van der Sangen, Niels M R, et al.
Publicado: (2023)

First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study
por: van Veelen, Anna, et al.
Publicado: (2023)

Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly
por: Claessen, Bimmer E.P.M., et al.
Publicado: (2015)

Diagnostic and Management Strategies in Patients with Late Recurrent Angina after Coronary Artery Bypass Grafting
por: de Winter, Ruben W., et al.
Publicado: (2022)

Residual Quantitative Flow Ratio to Estimate Post‐Percutaneous Coronary Intervention Fractional Flow Reserve
por: van Diemen, Pepijn A., et al.
Publicado: (2021)

Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction
por: Karami, Mina, et al.
Publicado: (2021)

Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin
por: Kikkert, Wouter J., et al.
Publicado: (2015)

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
por: Beijk, Marcel A.M., et al.
Publicado: (2010)

DEtection of ProxImal Coronary stenosis in the work-up for Transcatheter aortic valve implantation using CTA (from the DEPICT CTA collaboration)
por: van den Boogert, Thomas P. W., et al.
Publicado: (2021)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the eCTOpy‐in‐ICD Study)
por: van Dongen, Ivo M., et al.
Publicado: (2018)

Early mobilisation after transfemoral transcatheter aortic valve implantation: results of the MobiTAVI trial
por: Vendrik, J., et al.
Publicado: (2020)

Cardiology fellows-in-training are exposed to relatively high levels of radiation in the cath lab compared with staff interventional cardiologists—insights from the RECAP trial
por: Vlastra, W., et al.
Publicado: (2019)

Implementation of CT Coronary Angiography as an Alternative to Invasive Coronary Angiography in the Diagnostic Work-Up of Non-Coronary Cardiac Surgery, Cardiomyopathy, Heart Failure and Ventricular Arrhythmias
por: van den Boogert, Thomas P. W., et al.
Publicado: (2021)

Residual Inflammatory Risk After Percutaneous Coronary Intervention: Underappreciated But Modifiable
por: van Veelen, Anna, et al.
Publicado: (2022)

Emergency transfemoral valve-in-valve transcatheter aortic valve implantation in patient with chronic type A aortic dissection
por: Aarts, Hugo M., et al.
Publicado: (2023)

External validation of the GRACE risk score and the risk–treatment paradox in patients with acute coronary syndrome
por: van der Sangen, Niels M R, et al.
Publicado: (2022)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021)

Efficacy of Cangrelor as Bridging Therapy Post PCI
por: Khan, Abdul A., et al.
Publicado: (2020)

Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI
por: van den Buijs, Deborah M. F., et al.
Publicado: (2022)

Predicting hospitalisation duration after transcatheter aortic valve implantation
por: van Mourik, Martijn S, et al.
Publicado: (2017)

Percutaneous coronary intervention for chronic total coronary occlusion: Do. Or do not. There is no try
por: Knaapen, P., et al.
Publicado: (2020)

Correction to: Percutaneous coronary intervention for chronic total coronary occlusion: Do. Or do not. There is no try
por: Knaapen, P., et al.
Publicado: (2020)

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
por: van der Sangen, Niels M R, et al.
Publicado: (2023)

Data quality within the Netherlands Heart Registration: Ready for prime time?
por: van der Sangen, Niels M. R., et al.
Publicado: (2023)

Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease
por: Molenaar, Mitchel A., et al.
Publicado: (2022)

CTCA for detection of significant coronary artery disease in routine TAVI work-up: A systematic review and meta-analysis
por: van den Boogert, T. P. W., et al.
Publicado: (2018)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Impact of the COVID-19 Outbreak on the Treatment of Myocardial Infarction Patients
por: Grundeken, Maik J., et al.
Publicado: (2023)

A computed tomography algorithm for crossing coronary chronic total occlusions: riding on the wave of the proximal cap and distal vessel segment
por: Opolski, M. P., et al.
Publicado: (2020)

Patient-tailored antithrombotic therapy following percutaneous coronary intervention
por: van der Sangen, Niels M R, et al.
Publicado: (2021)

Cangrelor bridging strategy for liver damage after mechanical chest compression
por: Cereda, Alberto Francesco, et al.
Publicado: (2019)

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
por: van der Schaaf, René J, et al.
Publicado: (2010)

Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)
por: Cavender, Matthew A., et al.
Publicado: (2016)

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
por: Gutierrez, J. Antonio, et al.
Publicado: (2016)

Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards “Personalized Medicine” in Daily Clinical Practice
por: Chan Pin Yin, Dean R. P. P., et al.
Publicado: (2020)

Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
por: Gelbenegger, Georg, et al.
Publicado: (2022)

Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients
por: Prüller, Florian, et al.
Publicado: (2018)

Cangrelor ameliorates CLP-induced pulmonary injury in sepsis by inhibiting GPR17
por: Luo, Qiancheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hcov1j89jjkusit12cds3naper